Cancer Institute Medical Group

Santa Monica, California 90404

0 studies enrolling now · 8 studies all time

What they study most

Adenocarcinoma, Colorectal Cancer, Colorectal Neoplasms, Esophageal Neoplasms, Malignant Metastatic Melanoma, Melanoma, Non-Small-Cell Lung Carcinoma, Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer, Stomach Neoplasms

Studies at this site

• Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma — Completed
• Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma — Completed
• Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma — Completed
• STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) — Completed
• Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma — Completed
• A Study of ABT-751 in Patients With Colorectal Cancer — Completed
• Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer — Completed
• Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer — Stopped early